newsfilter
← Latest News
GlobeNewswire·

AlphaTON Capital Executes Binding Call Option to Sell Legacy Biotech Asset iOx Therapeutics to Immunova

Dover, DE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), the world's leading public technology company scaling the Telegram super app for an